ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1392

Familial Aggregation of Autoimmune Diseases in Childhood and Adulthood Systemic Lupus Erythematosus

Nailu A. Sinicato1, Luciana de Oliveira2, Aline Tamires Lapa2, Lilian Tereza Costallat3, Roberto Marini Sr.4, Timothy B. Niewold5 and Simone Appenzeller6, 1Pediatrics, State University of Campinas, Campinas, Brazil, 2Medicine, State University of Campinas, Campinas, Brazil, 3RUA EZEQUIEL MAGALHAES,26, Unicamp, Campinas, Brazil, 4Pediatric Rheumatology Unit, State University of Campinas, São Paulo, Brazil, 5Rheumatology and Immunology, Mayo Clinic, Rochester, MN, 6Pediatric Rheumatology Unit, State University of Campinas, Campinas, Brazil

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster II: Myositis, Systemic Lupus Erythematosus, Sjögren's Syndrome

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Genetic factors play a role in SLE, evidenced by the high sibling risk ratio (λs=8–29) and higher concordance rates between monozygotic twins (>35%) compared to dizygotic twins (2-5%). It is clear that the genetic basis of disease differs to some degree between ancestral backgrounds, and is less well understood in non-European ancestry subjects. In this study, we assessed the familial occurrence autoimmune disease in childhood-onset SLE (cSLE) and adult-onset SLE (aSLE) relatives in a large Brazilian cohort.

Methods:  cSLE patients (disease-onset ≤18 years) and aSLE patients (disease-onset >18 years) followed in the Pediatric and Adult Rheumatology Outpatient Clinic of the State University of Campinas were included. Each patient was personally interviewed regarding history of autoimmune diseases in three family generations (grandparents, parents and uncles/aunts, cousins and siblings). Recurrence rates were then calculated for each reported disease.

Results: We included 112 cSLE patients [96 (85.7%) women] and 266 aSLE patients [247 (92.9%) women]. In cSLE patients we identified 3812 relatives. In the first-degree kinship we observed 10 relatives with SLE, with a recurrence rate of 25.3 (25-fold greater risk of SLE than the general population). In the second-degree kinship we observed 10 relatives with SLE and 1193 relatives without, with a recurrence rate of 8.3. In the third-degree kinship we observed a recurrence rate of 0.9 (no increase over general population). In aSLE patients we identified 10584 relatives. In the first-degree kinship we observed a recurrence rate of 18.8. In the second-degree kinship the recurrence rate was4.6. The most frequent non-SLE autoimmune diseases observed in the family members were: hypothyroidism, hyperthyroidism, vitiligo, rheumatoid arthritis, psoriasis, systemic sclerosis, ankylosing spondylitis, inflammatory myopathy, Sjögren syndrome, Crohn’s disease.

Conclusion:  SLE recurrence rate is higher among first-degree relatives in both cSLE and aSLE patients, and steadily decreases between generations as would be expected for complex inheritance. Familial tendency toward SLE was higher in families with a cSLE patient, and recurrence rates were comparable or higher than those reported in European ancestry.


Disclosure: N. A. Sinicato, None; L. de Oliveira, None; A. T. Lapa, None; L. T. Costallat, None; R. Marini Sr., None; T. B. Niewold, None; S. Appenzeller, None.

To cite this abstract in AMA style:

Sinicato NA, de Oliveira L, Lapa AT, Costallat LT, Marini R Sr., Niewold TB, Appenzeller S. Familial Aggregation of Autoimmune Diseases in Childhood and Adulthood Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/familial-aggregation-of-autoimmune-diseases-in-childhood-and-adulthood-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/familial-aggregation-of-autoimmune-diseases-in-childhood-and-adulthood-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology